Financial Metrics Exploration: Understanding X4 Pharmaceuticals Inc (XFOR) Through Ratios

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

The closing price of X4 Pharmaceuticals Inc (NASDAQ: XFOR) was $1.16 for the day, up 3.10% from the previous closing price of $1.13. In other words, the price has increased by $3.10 from its previous closing price. On the day, 10.88 million shares were traded. XFOR stock price reached its highest trading level at $1.24 during the session, while it also had its lowest trading level at $0.9.

Ratios:

Our analysis of XFOR’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.34 and its Current Ratio is at 5.34. In the meantime, Its Debt-to-Equity ratio is 1.14 whereas as Long-Term Debt/Eq ratio is at 1.12.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on December 12, 2023, Downgraded its rating to Neutral and sets its target price to $1 from $3 previously.

On December 22, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $3.Cantor Fitzgerald initiated its Overweight rating on December 22, 2022, with a $3 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 11 ’24 when Mostafa Adam S. sold 52,500 shares for $0.88 per share. The transaction valued at 46,347 led to the insider holds 0 shares of the business.

Ragan Paula sold 49,678 shares of XFOR for $43,856 on Mar 11 ’24. The President and CEO now owns 765,068 shares after completing the transaction at $0.88 per share. On Mar 11 ’24, another insider, DiBiase Mary, who serves as the Chief Operating Officer of the company, sold 15,409 shares for $0.88 each. As a result, the insider received 13,591 and left with 291,752 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XFOR now has a Market Capitalization of 195647760 and an Enterprise Value of 139712512.

Stock Price History:

Over the past 52 weeks, XFOR has reached a high of $2.58, while it has fallen to a 52-week low of $0.57. The 50-Day Moving Average of the stock is 3.23%, while the 200-Day Moving Average is calculated to be 9.68%.

Shares Statistics:

XFOR traded an average of 2.48M shares per day over the past three months and 3423010 shares per day over the past ten days. A total of 167.43M shares are outstanding, with a floating share count of 122.08M. Insiders hold about 27.30% of the company’s shares, while institutions hold 35.95% stake in the company. Shares short for XFOR as of 1713139200 were 12264810 with a Short Ratio of 4.95, compared to 1710460800 on 14222812. Therefore, it implies a Short% of Shares Outstanding of 12264810 and a Short% of Float of 7.32.

Most Popular

[the_ad id="945"]